I. Introduction

R ECEPTORS coupled to heterotrimeric GTP-binding
proteins (G proteins) comprise the largest known family of cell surface receptors and mediate cellular responses to a diverse array of signaling molecules, including peptide and glycopeptide hormones, neurotransmitters, phospholipids, odorants, and photons. The basic unit of G protein-coupled receptor (GPCR) signaling is comprised of three parts; receptor, which detects ligand in the extracellular milieu; heterotrimeric G protein, which is dissociated into active Ga-GTP and G/37-subunits after interaction with the liganded receptor; and effector, which interacts with dissociated Ga-GTP and G/37-subunits to mediate the intracellular effects of ligand binding. In a given cell type, the responsiveness to stimulus, as well as the nature of the response, is dictated by the available complement of receptor, G protein, and effector.
Despite the diverse array of ligands with which they interact, GPCRs share a conserved predicted tertiary structure characterized by seven transmembrane domains joined by intracellular and extracellular loops. G protein coupling specificity is dictated by the intracellular domains, particu-larly the second and third intracellular loops and the Cterminal tail. Indeed, it is possible to alter the G protein coupling specificity of GPCRs by exchanging relatively small regions within the third intracellular loop (1) .
Heterotrimeric G proteins, whose crystal structure has recently been reported (2-5), consist of three heterologous subunits (a, j3, and 7) that are stably associated only in the inactive, GDP-bound, state. Noncovalent interaction between the G protein and an agonist-occupied receptor leads to the exchange of GDP for GTP on the a-subunit and its subsequent dissociation from the stable /37-dimer, resulting in the generation of two units capable of regulating intracellular signaling, Ga-GTP, and G/37. The receptor-G protein activation is catalytic; that is, one receptor may activate many G proteins before it is itself inactivated by phosphorylationdependent desensitization. The intrinsic GTPase activity of the Ga-subunit mediates the rate-limiting hydrolysis of GTP to GDP and the subsequent reassociation of the Ga/37-complex, thereby inactivating the G protein.
G protein a-subunits have been divided into subgroups based in part on their effector interactions. Gs proteins stimulate adenylyl cyclase; Gi/o family members are sensitive to inactivation by pertussis toxin (PTX) and often mediate inhibition of adenylyl cyclase. Gq/11 proteins are PTX insensitive and frequently couple receptors to activation of phospholipase C (PLC) isoforms.
In addition to Ga-GTP, G protein /37-subunits are involved in effector regulation, although little is known about the specificity of G/37-effector interactions. Examples of effectors that have been shown to be regulated by Ga-GTP and /or G/37-subunits include adenylyl cyclase, phospholipase C and A 2 isoforms, serine/threonine kinases, protein tyrosine kinases (6, 7), and many others.
II. G Proteins and GPCRs in Disease
While the role of activating mutations in tumor promoter genes, and inactivating mutations in tumor suppressor genes, has been the subject of intense investigation for some time, the clinical relevance of GPCR-signaling systems in regulating cell growth and differentiation has only recently been appreciated.
Our current understanding of the processes regulating cell growth, division, and differentiation has been derived largely from the study of transforming viral oncogenes and their cellular homologs, as well as the related pathways that regulate fruitfly, yeast, and nematode development. Much of
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" the work has focused on the role of receptor and nonreceptor protein tyrosine kinases as regulators of low molecular • weight G proteins, such as p21ras and its relatives (8,9). The low molecular weight G proteins, like their heterotrimeric counterparts, are signaling intermediates whose activation is y achieved by the exchange of GDP for GTP. Unlike the heterotrimeric G proteins, the low molecular weight G proteins * lack the intrinsic ability to catalyze GDP release and GTP hydrolysis and are therefore dependent on exogenous proteins, GEFs (guanine nucleotide exchange factors), GDIs . (GDP dissociation inhibitors), and GAPs (GTPase activating proteins), for their regulation (10). Recruitment of these reg-*-ulators of low molecular weight G protein function is, in y many cases, directed by specific protein-protein interactions controlled by tyrosine phosphorylation.
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Nonetheless, naturally occurring activating and inactivating mutations of both GPCRs and heterotrimeric G proteins are associated with several disease states (11,12). Mutations 1.4, resulting in the constitutive activation of the TSH receptor result in hyperfunctioning thyroid adenomas with hyper-•** thyroidism (13). Similarly, a rare autosomal disease known as familial precocious puberty results from an activating mutation in the receptor for LH (14) . The discovery of thesê naturally occurring mutations were anticipated by early findings that constitutively active a 1B -, /3 2 -, and a 2A -y w adrenergic receptors generated in vitro lead to an increase v in the basal activity of G protein-mediated signaling pathways (15-17). An activated mutant of the a 1B -adrenergic receptor has been shown to exhibit agonist-independent transforming properties in NIH 3T3 cells, thus predicting """ K the oncogenic potential of constitutively activated GPCRs ->. (18) .
The function of heterotrimeric G proteins as oncogenes has t -4 recently been reviewed in detail (19) . Activating mutations of Gas, which increase the basal activity of downstream effectors (20,21), have been recovered from human pituitary *. and thyroid adenomas (20, (22) (23) (24) (25) (26) . Constitutively active mutants of Gs are associated with McCune-Albright syndrome, * a disease characterized by polyostotic fibrous dysplasia and A hyperfunction of multiple endocrine glands (14) and have been found as somatic mutations in pituitary somatotrophs A and thyroid cells. Many of these gain-of-function mutations localize to the GTPase domain of the Ga-subunit where they *" inhibit the ability of G a to hydrolyze GTP to GDP, preventing its inactivation and reassociation with the 07-complex.
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III. Growth-Promoting Effects of GPCRs
p». v, Several ligands that signal via GPCRs have been shown to elicit mitogenic responses, including stimulation of DNA * synthesis, expression of nuclear oncogenes, and cell prolifk eration. In Chinese hamster lung fibroblasts, DNA synthesis stimulated by thrombin, but not by platelet-derived growth > factor (PDGF), is blocked by PTX treatment, implicating PTXsensitive Gi/o proteins in mitogenic signaling (27). The prov liferative effects of serum have been shown to be due primarily to PDGF and lysophosphatidic acid (LPA), the simplest naturally occuring phospholipid (28). PDGF acti--r vates a receptor tyrosine kinase (RTK), while LPA mediates intracellular signaling via both PTX-sensitive and -insensitive G proteins (28). Both PTX-sensitive and -insensitive proliferative responses have been observed in cells treated with adenosine (29), substance P and substance K (30), thrombin (30-32), and bombesin (33, 34).
The ability of LPA to stimulate DNA synthesis in Rat-1 fibroblasts is completely inhibited by PTX treatment, demonstrating the involvement of Gi/o proteins in cellular mitogenesis. In NIH 3T3 cells, the serotonin 5HTlb receptor mediates a PTX-sensitive increase in the rate of DNA synthesis (35), and serotonin 5HTlc receptors increase focus formation in an agonist-dependent manner (36). Cells isolated from 5HTlc-transformed foci form tumors when injected into nude mice, indicating that these receptors function as ligand-dependent protooncogenes in fibroblasts. In contrast, the Gi/o-coupled m2 and m4 acetylcholinergic receptors (AChRs) fail to induce transformation in these cells (37). The mitogenic effects of serotonin are synergistic with those of PDGF (38).
In human diploid fibroblasts, the Gq/11 -coupled bradykinin receptor does not elicit a proliferative response (28). In contrast, the ml, m3, and m5 subtypes of the AChRs, which also couple to PTX-insensitive Gq/11 proteins, increase the rate of formation of transformed foci in an agonist-dependent manner in NIH 3T3 cells (37). Diversity must therefore exist both within and between cell types, in the mechanisms whereby GPCRs transduce mitogenic signals.
IV. Regulation of Mitogen-Activated Protein (MAP) Kinases by GPCRs
The ubiquitous MAP kinases comprise a family of serine/ threonine kinases that are involved in the transduction of externally derived signals regulating cell growth, division, and differentiation. Depending upon the cellular context, activated MAP kinases may mediate pleiotropic responses in the membrane, cytoplasm, nucleus, or cytoskeleton. Upon activation, MAP kinases translocate to the nucleus, where they phosphorylate and activate nuclear transcription factors involved in DNA synthesis and cell division (39).
The first detected and best studied of the MAP kinases are the extracellular signal-regulated kinases (ERK) 1 and 2 (p4 4 ma P K a n d p 42 mapk) R e g u i a t i o n o f gRKl and ERK2 occurs via an evolutionarily conserved kinase cascade related to signaling pathways found in organisms as divergent as fruitflies and yeast (40). The proximal kinases in the mammalian ERK1/2 pathway, Raf-1 and B-Raf [MAP kinase kinase kinase (MAPKKK)], phosphorylate and activate MEK1 and MEK2 [MAP kinase kinase (MAPKK)]. The dual function threonine/tyrosine MEKs, in turn, mediate the activation of ERK1 and ERK2 (MAPK).
Other members of the mammalian MAP kinase family include two ERK3 isozymes, ERK5 (41), three distinct Jun N-terminal kinases/stress-activated protein kinases (JNK/ SAPK), two p38 MAP kinases, and p57 MAP kinases (40). Although all of the intermediates are not yet fully characterized, regulation of each of these kinases occurs via a MAP-KKK, MAPKK, MAPK phosphorylation cascade that reprises the ERK1 /2 paradigm. Thus, cells contain a series of parallel
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MAP kinase-signaling cascades, potentially under independent regulation, each of which can initiate a pattern of regulated gene expression.
A. Extracellular-signal regulated kinases (ERKs)
Activation of the ERK1 /2 cascade by peptide growth factors such as epidermal growth factor (EGF), PDGF, and fibroblast growth factor (FGF) has been studied extensively (9). The EGF, PDGF, and FGF receptors are single transmembrane domain proteins that possess intrinsic ligandstimulated tyrosine kinase activity. Upon ligand binding, these RTKs dimerize and transphosphorylate on their cytoplasmic domains. The resulting phosphotyrosine residues serve as docking sites to recruit components of the mitogenic signaling complex to the receptor.
Recruitment of adapter proteins, such as She and Grb2, to the phosphorylated RTK serves to assemble a multiprotein complex for regulating the low molecular weight G protein p21ras. The p21ras guanine nucleotide exchange factor Sosl is stably associated with Grb2; thus recruitment of Grb2 brings Sosl to the cytoplasmic surface of the membrane where it activates p21ras by catalyzing GDP for GTP exchange. GTP-bound p21ras initiates the ERK1/2 kinase cascade by activating the Raf-1 serine/threonine kinase, followed by the sequential phosphorylation and activation of the MEK and ERK1/2 kinases (Fig. 1) .
The assembly of this membrane-associated mitogenic signaling complex is dependent upon modular domains in the component proteins, which dictate the specificity of proteinprotein interactions. Src-homology 2 (SH2) domains, which are present in both the She and Grb2 adapter proteins, mediate high-affinity binding to specific phosphotyrosine (pTyr) residues. In addition to its C-terminal SH2 domain, She has a second structurally unrelated pTyr-binding (PTB)
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FIG. 1. The activation of the p21ras/ERK-signaling pathway by RTKs. The binding of ligand to the extracellular domain of RTKs, such as the EGF and PDGF receptors, leads to receptor dimerization and autophosphorylation. The resulting phosphotyrosine residues on the intracellular domain of the RTK serve as high-affinity binding sites for SH2 domain-containing proteins such as the She and Grb2 adapter molecules. Grb2, in turn, recruits the Sosl guanine nucleotide exchange factor into the signaling complex via an SH3 domain-mediated interaction. Sosl catalyzes the exhange of GDP for GTP on p21ras, leading to its activation. GTP-bound p21ras binds to and activates Raf kinase, thereby initiating a kinase cascade resulting ultimately in the stimulation of ERK1/2 activity. domain at its N terminus, which dictates receptor-She interaction. SH3 domains bind with high affinity to proline-rich regions of proteins. The SH3 domain of Grb2 mediates its binding to the C terminus of the Sosl guanine-nucleotide exchange factor. Other components of the complex, including Sos and Ras-GAP, contain pleckstrin-homology (PH) domains, which have been shown to bind to both G/37-subunits (42) and phospholipids (43-45).
As with the RTKs, activation of the ERK1/2 cascade by GPCRs signaling via PTX-sensitive and -insensitive G proteins has been reported for a broad array of ligands. These include angiotensin II (46), somatostatin (47), endothelin-1 (48-51), thromboxane A2/prostaglandin H2 (52, 53), interleukin-8 (54), platelet-activating factor (PAF) (55), bombesin (56), formyl-methionyl peptide (fMLP) (57), C5a peptide (58), TRH (59), sphingosine-1-phosphate (60-62), oxytocin (63), and LHRH (64). Despite observations that GPCRs can mediate growth factor-like effects, the mechanisms by which these receptors mediate ERK activation were not studied in detail until recently. Since GPCR signals are transduced via heterotrimeric G proteins, it is useful to consider the mechanisms whereby the different Ga-and G/37-subunits communicate with the ERK1/2 cascade. The mechanism employed by each receptor is determined by the G protein(s) with which it interacts and the available effectors in a particular cell type.
Gs.
Constitutively active mutants of the Gs-coupled TSH receptor have been isolated from hyperfunctioning thyroid adenomas (13), suggesting a role for Gs in the regulation of cell growth. In COS-7 cells, stimulation with isoproterenol, a /3-adrenergic agonist, results in activation of cAMP-dependent protein kinase A and ERK1/2 (65). Similar effects were reported for transiently expressed LHRH receptor and constitutively activated Gs in these cells (66).
Despite these observations, the role of Gs in regulation of cell growth is complex and apparently cell type-specific. In fibroblasts, cAMP inhibits RTK-mediated ERK1 /2 activation (67-69). Forskolin-treated NIH 3T3 cells show decreased responsiveness to EGF and LPA (70) , reflecting reduced activation of Raf, MEK, and ERK, but not p21ras (71) (72) (73) . Increased cAMP levels are associated with increased phosphorylation of Ser-43 of the Raf-regulatory domain, resulting in reduced affinity of Raf for p21ras (67) . ERK activity in p21ras-transformed Rat-1 fibroblasts is inhibited by treatment with 8-bromo-cAMP, consistent with cAMP-mediated inhibition at a step downstream of p21ras (68) . In contrast, Faure and Bourne (74) have observed a lack of forskolinmediated ERK inhibition in Swiss 3T3 and COS-7 cells while others have reported an activating role for cAMP on ERK activation in PC12 cells (75, 76) . This lack of inhibition apparently results from differential sensitivity of Raf-1 and B-Raf to cAMP-mediated inhibition and suggests the existence of a Raf-1 independent, cAMP-insensitive pathway in these cells.
Crespo et ah (65) have proposed that, in COS-7 cells, Gscoupled receptors mediate simultaneous, opposing effects. They suggest that the G/37-subunits derived from Gs mediate ERK1 /2 activation, while cAMP generated by Gas-mediated activation of adenylyl cyclase opposes this effect. Thus, the f V nature of the cellular response to j3-adrenergic agonists in these cells is determined by the balance between two opposing signals.
Gi.
Constitutively active Gcti2, gip2: A direct role for Gai in oncogenesis was first postulated when a constitutively active, GTPase-deficient mutant of Gai2, gip2, was isolated from several human endocrine tumors and subsequently shown to induce neoplastic transformation of Rat-1 fibroblasts (77) . NIH 3T3 cells stably transfected with gip2 demonstrate an increased rate of DNA synthesis (78) , but gip2 does not cause complete transformation of NIH 3T3 fibroblasts, suggesting that its oncogenic potential is tissue specific (77, 79) .
The mechanism by which gip2 transmits mitogenic signals remains unclear. p21ras Activation is apparently not required for gip2-mediated cellular proliferation (79, 80) , suggesting that the mitogenic signaling pathway differs from that mediated by RTKs. The most readily detectable effect of gip2 expression is a sustained inhibition of adenylyl cyclase activity (81) , resulting in a decreased basal level of cAMP.
Since cAMP opposes ERK1/2 activation in many cell types, the observation that the gip2 oncogene transforms Rat-1 fibroblasts may reflect its constitutive inhibition of adenylyl cyclase. This model predicts that decreased intracellular levels of cAMP would relieve cAMP-mediated inhibition of Raf and permit increased ERK activity.
Agonist-stimulated mitogenic signaling through Gi: p21ras-Dependent activation of ERK1/2 via Gi-coupled receptors was initially described by three laboratories (82) (83) (84) (85) . The receptors for LPA and a-thrombin mediate activation of p21ras (82), Raf-1, and ERK1/2 (83) . The signals are PTXsensitive, indicating the involvement of a Gi/o family heterotrimeric G protein. Stimulation of the a 2A -adrenergic receptor (a 2A AR), which is specifically coupled to Gi2 and Gi3, leads to rapid and transient activation of p21ras and ERK in Rat-1 fibroblasts (84) . These responses are unrelated to inhibition of adenylyl cyclase and dissociable from PLC activation. Carbachol stimulation of Rat-1 cells expressing the Gi-coupled M 2 AChR leads to the PTX-sensitive activation of p21ras, Raf, MEK, and ERK (85) . The p21ras dependence of these signals distinguishes them from gip2-mediated cell transformation (79, 80) , suggesting, instead, the existence of a distinct pathway with at least some features in common with RTK-mediated mitogenic signaling.
The analogy to RTK signaling was strengthened by the finding that LPA-mediated p21ras and ERK activation is sensitive to inhibition by low concentrations of the tyrosine kinase inhibitor genistein (82) . Subsequent experiments revealed that LPA stimulation of Rat-1 cells increases tyrosine phosphorylation of several proteins (86) . TRH (59), endothelin (87), angiotensin II (88), thrombin (89), LPA, and a 2A -adrenergic receptors (90, 91) stimulate tyrosine phosphorylation of the She adapter protein and its subsequent association with Grb2. These data suggest that RTK-and Gi-mediated mitogenic signals converge at or above the level of the pTyr-dependent Shc-Grb2 interaction.
Chemoattractant receptors, such as the fMLP receptor, also activate the Gi-mediated p21ras-dependent ERK pathway (57). In human polymorphonuclear leukocytes, fMLP activates p21ras, Raf, and ERK in a PTX-sensitive manner. Consistent with the findings in fibroblasts and Chinese hamster ovary (CHO) cells, treatment of neutrophils with inhibitors of protein kinase C does not affect fMLP receptor-mediated ERK1/2 activation. Recently, fMLP was also shown to stimulate PTX-sensitive tyrosine phosphorylation of She as well as the association of She with Lyn, a Src family non-RTK (92).
The mounting evidence that Gi-coupled receptors can mediate increases in tyrosine protein phosphorylation and p21ras-dependent activation of ERK1/2 contrasts with the lack of effect on these pathways in cells expressing the activated Gai mutant, gip2. Indeed, Gi-coupled receptor-mediated ERK1/2 activation is not attributable to known effectors of G proteins, such as inhibition of adenylyl cyclase, PLC activation, or modulation of ion channels (82, 84) . The resolution of this apparent paradox seems to reside in a novel signaling pathway regulated by Gj3y-subunits.
3. G protein fiy-subunits. G protein /37-subunits were originally thought to function as structural proteins required for the membrane localization and inactivation of Ga-subunits. Appreciation of the role of Gj3y-subunits as regulators of GPCR effector molecules has developed more recently (6). Gj3y-subunits are now known to directly regulate an array of effector molecules, among them /3-adrenergic receptor kinase (|3ARK1) (93, 94), PLC-j3 (95-105), phospholipase A 2 (106), types II and IV adenylyl cyclases (107,108), phosducin (109), muscarinic K + channels (110-112), PH domain-containing tyrosine kinases (7, 113), phosphatidylinositol-3 kinase (PI3K) (114), and N-type Ca ++ channels (115, 116). Evidence that G-protein /37-subunits are capable of transmitting mitogenic signals initially came from three laboratories (66,117,118). In COS-7 cells, Crespo et al. (117) found that ERK1 /2 activation via both the PTX-sensitive G proteincoupled M 2 AChR and PTX-insensitive G protein-coupled M^ChR receptors was attenuated by coexpression of the a-subunit of transducin, which acts to sequester G/3y-subunits released upon stimulation from endogenous G proteins. Koch et al. (118) performed similar experiments using the carboxy-terminal fragment of the /3ARK1 enzyme (j3ARKct), which contains the G/3y-binding domain of the kinase (119), as a sequestrant of free G/3y-subunits. Expression of /3ARKct significantly inhibits ERK1/2 activation by the Gi-coupled « 2A AR and M 2 AChR in transiently transfected COS-7 cells. Similarly, /3ARKct overexpression antagonizes activation of both pilras and ERK1/2 via the endogenous LPA receptor. Since a constitutively active mutant of Gai2 did not increase ERK activity in COS-7 cells (66), the mitogenic signals mediated by Gi-coupled receptors appear to be entirely dependent on a Gj3y-mediated pathway. Furthermore, transient transfection of Gj3 and Gy cDNAs into COS-7 cells results in a sustained increase in the basal level of ERK activity, indicating that Gj3y-subunits alone are sufficient for ERK activation (66, 117).
The Py-stimulated ERK activation pathway. Expression of constitutively active Gaq, unlike the Gai mutant, is sufficient to induce activation of ERK1 /2 in COS-7 cells (66), indicating that Gq-coupled receptors activate additional signaling pathways. To differentiate the Gi-and Gq-mediated mitogenic signaling pathways in COS-7 cells, Hawes et ah (120) compared the effects of Gi-and Gq-coupled receptors on both PI hydrolysis and ERK1/2 activation. The Gi-coupled O^AAR signals, but not those mediated by the Gq-coupled a 1B AR and IV^AChR, were sensitive to inhibition by the /3ARKct peptide, suggesting that the Gq/11-coupled receptors mediate ERK1/2 activation, as well as PI hydrolysis, via a predominantly Ga-mediated mechanism.
Coexpression of combinations of G/3 and G7 cDNAs in COS-7 cells revealed that those pairs known to form functional Gj3y-complexes (/31yl, /31y2, j31y3, and /32y2) (121-124) stimulated both ERK1 and PI hydrolysis (120). Both processes were abrogated by coexpressed jSARKct peptide. Dominant negative mutants of p21ras (N17Ras) and Raf (NARaf) specifically inhibited G/3y-mediated ERK activation, without affecting PI hydrolysis. Thus, expression of Gj3y-subunits was sufficient to mimic Gi-coupled receptor-mediated activation of p21ras, Raf, and ERK (82, 84, 85) .
Shc-Grb2-Sos complex formation. The effect of Gj3y-subunits on ERK1 activation can be differentiated from their effect on PI hydrolysis using inhibitors of protein tyrosine kinases (PTKs) (120). The PTK inhibitors genistein and herbimycin A attenuate G/3y-stimulated ERK activation in a dose-dependent manner, with no effect on Gj3y-stimulated inositol phosphate production. The PTK inhibitors have no effect on ERK activation mediated by a constitutively active mutant of p21ras (T24Ras) (125), indicating that the inhibitor-sensitive step lies upstream of p21ras. Thus, activation of PLC by Gj3y-subunits is not sufficient to account for activation of the ERK pathway. Rather, G/3y-subunits appear to require the activity of a PTK to mediate ERK activation, supporting the hypothesis that Gi-coupled receptors activate mitogenesis by elevating the intracellular level of tyrosine kinase activity (86) .
In the RTK-mediated ERK pathway, tyrosine phosphorylation of the She adapter protein allows it to serve as a docking protein for the assembly of the mitogenic signaling complex that leads to p21ras activation. The G protein-coupled endothelin (87), LPA (90), a^AR (42), angiotensin II (88), thrombin (89), and TRH (59) receptors mediate an agonist-dependent increase in the tyrosine phosphorylation of the She adapter protein. LPA-and a^A-AR-mediated She tyrosine phosphorylation is sensitive to both PTX and the j3ARKct peptide and can be mimicked by expression of Gj3y-subunits.
The tyrosine phosphorylation of She is accompanied by a simultaneous increase in complex formation between She and Grb2 (90, 88). Shc-Grb2 complex formation is rapid and transient, preceding the maximum level of ERK activation. Since Grb2 and Sosl are constitutively associated, the GjSydependent recruitment of Grb2 to tyrosine-phosphorylated She results in increased She-associated guanine-nucleotide exchange factor activity (90).
These findings suggest that GPCRs and RTKs can induce p21ras activation via convergent signaling pathways (Fig. 2) . Dominant negative mutants of mSosl demonstrate a requirement for Sosl in G/3y-mediated ERK activation (90). When expressed in COS-7 cells, a peptide derived from the prolinerich C terminus of mSosl, containing the Grb2 binding site (Sos-Pro), competitively inhibits the formation of functional Gi-coupled receptors, such as the LPAR and a 2A AR, stimulate ERK1/2 activity via a mechanism that is mediated entirely by G protein /3y-subunits and which, in part, reprises the RTK paradigm (see Fig. 1 ). G/3y stimulates c-Src kinase activity, resulting in the phosphorylation of a variety of cellular substrates, including the She adapter protein and RTKs, thereby activating the signaling pathway described in Fig. 1 . The nature of the involvement of RTKs in G/3y-mediated ERK1/2 activation remains unclear. Furthermore, c-Src activation by Gj3y occurs via a poorly understood mechanism that appears to involve PI3K activity and possibly an as yet unidentified effector protein.
Shc-Grb2-Sosl-signaling complexes. In cells stimulated by EGF, G)3y, or the Gi-coupled a 2A AR, Sos-Pro expression completely inhibited ERK activation, whereas mitogenic signaling by constitutively active T24Ras was unaffected (90). Thus, Gj3y-subunits apparently direct the assembly of a p21ras-activation complex, at the plasma membrane, which contains many of the intermediates employed by the RTKs and which is dependent upon Gj3y-subunit-mediated tyrosine phosphorylation.
PTKs. This early convergence of signaling pathways represents a previously unappreciated degree of cross-talk between the RTK and GPCR families of receptors. In each case, receptor activation leads to increased tyrosine phosphorylation. The intrinsic tyrosine kinase activity of the RTKs is required for their ability to signal. The identity of the tyrosine kinase(s) involved in GPCR signaling remains unclear, although data suggest that both RTKs and non-RTKs may be involved.
Recently, Linseman et ah (126) demonstrated that angiotensin II and PDGF activate a common mitogenic signaling cascade in vascular smooth muscle cells. Treatment of vascular smooth muscle cells with either angiotensin II or PDGF resulted in a rapid increase in She tyrosine phosphorylation and Shc-Grb2 complex formation. Furthermore, a 180-kDa protein coprecipitating with Shc-Grb2 complexes also demonstrated increased tyrosine phosphorylation in response to angiotensin II. This coprecipitating protein was identified as the PDGF receptor, suggesting that angiotensin II mediates mitogenic signaling by inducing phosphorylation of the PDGF-RTK (126). This effect is sensitive to inhibition by an antagonist of the angiotensin II type I receptor and does not involve autocrine activation of the PDGF receptor. Comparable results were reported by Daub et ah (127), who found increased tyrosine phosphorylation of the EGF-RTK in response to the GPCR agonists endothelin-1, LPA, and thrombin. EGF-RTK phosphorylation occurred concomitantly with increased binding of both She and EGF-RTK to a GST fusion protein containing the Grb2 SH2 domain, suggesting that the mitogenic signaling complex is assembled on the cytoplasmic surface of the EGF-RTK (127). The EGF-RTK-specific tyrosine kinase inhibitor, tyrphostin AG1478, blocked GPCRmediated EGF-RTK phosphorylation and ERK activation, suggesting that the receptor's intrinsic tyrosine kinase activity was required for GPCR-mediated mitogenic signaling. A dominant negative mutant of the EGF-RTK, HERCD533, had identical effects. The authors suggest that the intrinsic tyrosine kinase activity of RTKs may be modulated in a ligand-independent manner by GPCR-mediated signals and that the RTKs themselves may function as scaffolds in GPCR signaling (127).
GPCR-mediated tyrosine phosphorylation of the insulin growth factor 1 (IGF-1) receptor, insulin receptor substrate (IRS-1) (128), and focal adhesion kinase (FAK) (86) have also been reported. Like the EGF-RTK, PDGF-RTK, and She, each of these molecules can function as a docking protein when phosphorylated, and each participates in mitogenic signaling via RTKs or integrins. Collectively, these data suggest that GPCRs mediate a program of tyrosine protein phosphorylation that is required for mitogenic signaling. Other receptors that lack intrinsic tyrosine kinase activity, such as the GH or erythropoietin receptors and the antigen receptors of T cells and B cells, accomplish this via the recruitment and activation of non-RTKs of the Src and/or Janus kinase families (129-132).
Several lines of evidence suggest a role for the ubiquitous nonreceptor Src-family tyrosine kinases in signaling via GPCRs. Activation of the Src family kinases, c-Src, Fyn, or Yes, by the thrombin (133), endothelin (134), and angiotensin II (126,135,136,137) receptors has been reported. Similarly, the N-formyl peptide chemoattractant receptor of polymorphonuclear leukocytes has been shown to mediate an agonist-dependent increase in complex formation between tyrosine-phosphorylated She and Lyn, a Src-family tyrosine kinase (92). In COS-7 cells, GPCR-dependent She tyrosine phosphorylation is dependent upon the c-Src tyrosine kinase (138). Stimulation of several Gi-coupled receptors leads to a rapid increase in c-Src autophosphorylation, c-Src activity, and the formation of a c-Src-Shc complex (133, 138). These effects are sensitive to PTX and |3ARKct, indicating that the signal is mediated by G/3y-subunits derived from PTX-sensitive G proteins. Transfection of cells with Csk (C-terminal Src Kinase), an inhibitor of Src-family tyrosine kinases (139-142), results in the inhibition of She tyrosine phosphorylation and ERK activation (138), indicating that c-Src activity is required for Gj3y-mediated ERK activation (Fig. 2) . Nuclear signaling by endothelin-1 also appears to require Src-family tyrosine kinases (143). Activation of c-fos transcription by endothelin-1 was inhibited by both Csk and a dominant negative mutant of c-Src, indicating that nonreceptor protein-tyrosine kinases play a vital role in GPCR-mediated cell growth and development.
Cellular expression of mutationally activated c-Src results in She phosphorylation, Grb2 recruitment, and p21ras-dependent activation of ERK1/2. Regulation of Src-family kinases by GPCRs might also account for the phosphorylation of RTKs mediated by some GPCRs. Src kinases have been shown to associate with the EGF-RTK and ErbB2 (pl85neu) in mammary tumor cell lines (144), and with She in v-sretransformed cells (145). Furthermore, a kinase-inactive mutant of the EGF-RTK retained its ability to stimulate DNA synthesis upon EGF stimulation (146). The authors postulate that this mutant was phosphorylated on tyrosine in response to EGF by an associated tyrosine kinase. Activated c-Src directly phosphorylates several non-autophosphorylation sites on the cytoplasmic surface of the EGF-RTK, which then serve as high-affinity binding sites for both c-Src and the p85 subunit of PI3K (147, 148). Whether or not this phosphorylation of the receptor affects its intrinsic tyrosine kinase activity is unknown. However, c-Src and p85 exhibit a higher affinity for c-Src-phosphorylated EGF-RTK than for autophosphorylated EGF-RTK (147). The angiotensin II-mediated mitogenic signal (126) also involves the phosphorylation and recruitment of c-Src into a complex containing the PDGF-RTK, She, and Grb2.
Janus kinases (JAK) mediate the phosphorylation and activation of the STAT (signal transducers and activators of transcription) transcription factors (149). JAK2 also plays a role in ERK1/2 activation via the GH receptor, where JAK2 recruitment and activation are required for She phosphorylation and p21ras-activation (132,150). Little is known about the involvement of JAK kinases in GPCR signaling. The angiotensin II type I receptor mediates direct activation of the JAK/STAT pathway (151), but as yet there is no evidence supporting a role for JAK in ERK activation pathways.
FAK is a tyrosine kinase involved in signaling via the integrin receptors, which convey information from the cellular substratum (152) . Activated FAK autophosphorylates, and forms signaling complexes at focal adhesions that contain c-Src, paxillin, dynamin, and Grb2. Increased FAK phosphorylation after stimulation of endothelin I, bombesin (153) , and Ml muscarinic (154) , adrenergic, and thromboxane A2 GPCRs has been reported. The mechanism of FAK activation by GPCRs is unclear. Phosphorylation of FAK by LPA receptors in Rat-1 cells is mediated by PTX-insensitive G proteins, suggesting that GPCR-induced FAK phosphorylation is independent of the PTX-sensitive ERK1/2 activation pathway (86) . Botulinum C3 toxin blocks bombesin and endothelin-induced FAK and paxillin phosphorylation, implicating the low molecular weight G protein Rho in the process. Still, the recruitment of the Grb2 adapter protein into focal adhesion complexes after GPCR stimulation suggests a mechanism for GPCR-mediated p21ras activation that might employ the focal adhesion complex as a scaffold.
PI3K. The p85/pllO isoform of PI3K (PI3Ka) is a heterodimeric enzyme composed of a regulatory subunit (p85) and a catalytic subunit (pi 10), which catalyzes the 3'-phosphorylation of inositol phospholipids. PI3Ka is regulated by SH2-mediated binding to tyrosine-phosphorylated proteins such as RTKs, She, and IRS-1. PI3Ka may function as a downstream effector of p21ras (155) (156) (157) in the activation of the small molecular weight G proteins Rho and Rac. PI3Ks may also function upstream of p21ras (158, 159) , perhaps as a regulator of growth signals (158, (160) (161) (162) (163) . Hu et al. (160) reported that expression of a constitutively active mutant of PI3Ka increased both p21ras and ERK activity in Xenopus oocytes, indicating that PI3Ka can function as a protooncogene. Using antibodies against the pi 10 subunit of PI3Ka, Roche et al. (162) demonstrated a requirement for PI3K ac-Vol. 17, No. 6 tivity in PDGF-and RTK-mediated entry of quiescent cells into S phase. The p85 subunit of PBKa is known to bind with high affinity to several mitogenic signaling intermediates, including Shc-Grb2 (158) and RTKs such as the EGF-RTK (147) and PDGF-RTK (164) (165) (166) . Activation of c-fos transcription by insulin is sensitive to inhibition by transfected p85 subunit, whereas insulin-mediated p21ras and Raf activation are unaffected (159) . These data suggest a potential role for PBK activity in growth factor-mediated mitogenic signaling.
Recently, G/3y-mediated ERK activation in COS-7 and CHO cells was shown to be sensitive to inhibition by two specific inhibitors of PBKs, wortmannin and LY294002 (167, 168) . These drugs also impaired LPA-mediated activation of p21ras (167) and Gj3y-stimulated phosphorylation of She (91). In contrast, expression of a constitutively activated mutant form of PBKa (160) in COS-7 cells failed to induce ERK1/2 activation (T. van Biesen and R. J. Lefkowitz, unpublished observations) while thrombin-induced mitogenic signals in Swiss 3T3 cells were shown to occur in the absence of PI3K activation (158) . Thus, while PI3K activity is apparently involved in mitogenic signaling in some cell types, it is not sufficient to mediate p21ras-dependent ERK1/2 activation.
A possible clue to the role of PBKs in mitogenic signaling upstream of p21ras comes from Rameh et ah (169) , who found that the product of PI3K activity, phosphatidylinositol-3,4,5-trisphosphate (PIP 3 ), has a high binding affinity for the SH2 domains of various proteins, including Src and the p85 subunit of PI3K. Competition between PIP 3 and the tyrosinephosphorylated SH2 binding site for p85 on IRS-1 apparently provides feedback-inhibitory control of PBK activity after insulin stimulation. The authors postulate that similar interactions between PIP 3 and the c-Src SH2 domain might activate c-Src by displacing the interaction between the c-Src SH2 domain and its tyrosine-phosphorylated C terminus.
A novel isoform of PBK, pi lOy or PBKy, has recently been cloned (114, 170) . PBKy is a monomeric enzyme that undergoes conditional stimulation by G/3y-subunits in vitro and is sensitive to inhibition by wortmannin. Whether PBKy functions as a proximate effector of G/3y-subunits in the ERK1/2 activation pathway remains unclear, since wortmannin and LY294002 cannot distinguish between the p85/ pi 10 and PBKy-mediated signals.
Protein tyrosine phosphatases. A role for protein-tyrosinephosphatases such as SHP2 has been described for mitogenic signaling mediated by growth factors such as insulin (171) (172) (173) and PDGF (174, 175) and appears to be required for early Xenopus development (176) . One of its functions may be to mediate dephosphorylation of the C-terminal regulatory tyrosine residue of c-Src family kinases, thereby stabilizing the kinase in the active state. SHP2 forms active signaling complexes containing Grb2 and PBK (177) and may be required for PDGF-mediated p21ras activation (175) . Recently, Rivard et ah (178) reported the involvement of SHP2 in fibroblast proliferation mediated by both PDGF and thrombin, suggesting a role for GPCR-mediated activation of proteintyrosine-phosphatases in mitogenic signaling. Similarly, phosphotyrosine phosphatase activity is detectable after stimulation of the somatostatin SSTR1 receptor in CHO-K1 cells (179) and a human pancreatic cell line (180) .
PH domains in mitogenic signaling:
The j3ARKct peptide used as a sequestrant of G/3y contains the region of the /3ARK1 enzyme shown to bind reversibly to purified Gj3y-subunits in vitro (93,119). This region of the kinase contains a PH domain (119), a common structural motif found in more than 90 proteins (181, 182) , including guanine-nucleotide exchange factors such as Sosl, GTPase-activating proteins such as Ras-GAP, phospholipases, cytoskeletal proteins, and PTKs.
PH domains of several proteins reversibly bind with high affinity to G/3y-subunits in vitro, including those of Ras-GRF, Ras-GAP, PLC-y, IRS-1, Dbl (42, 183), and Btk (184) . Transient expression of these PH domains inhibits G/3y-subunitmediated PI hydrolysis and the activation of p21ras and ERKs (118,185), suggesting that the ability to sequester free Gj3y-subunits is a shared property. However, binding of G/3y-subunits is not a universal property of PH domains. The PH domain of spectrin, for example, does not detectably bind G/3y in vitro (42). Furthermore, many Gj3y-binding proteins including Ga-subunits, G protein-gated K + channel (186), Raf-1 (187), and phosducin (109,188) lack PH domains. Phosducin, like the j3ARKct peptide, competitively inhibits Gj3y-mediated functions (189) .
The structures of several PH domains have been reported (190) (191) (192) (193) (194) (195) and consist of seven antiparallel j3-strands forming a j3-barrel with an amino-terminal a-helix. Binding of Gj3y-subunits to the jSARKlct requires the C-terminal portion of the PH domain plus a short sequence distal to it. The N-terminal /3-barrel portion of PH domains apparently mediates phospholipid binding, with highest affinity for phosphatidylinositols such as phosphatidylinositol-4,5-bisphosphate (PIP 2 ) (44, 196, 197) , phosphatidylinositol-3,4,5-trisphosphate (PIP 3 ) (198) , and inositol trisphosphate (45). These observations suggest that PH domains may coordinate interactions between inositol phospholipids, notably the products of PBK activity, and membrane proteins, such as Gj3y-subunits, thereby providing a unique mechanism of inducible membrane-protein interaction (169, 199) . Indeed, optimal translocation and activation of /3ARK in vitro requires both PIP 2 and G/3y-subunits (44). Mutational disruption of either the j3-barrel or a-helical portions of the PH domain compromises function (43).
Among the PH domain-containing proteins is a family of PTKs, including Btk, Tsk, Tec, Itk, and Bmx (200, 201) . Expression of these Btk family kinases is generally limited to the hematopoietic system where they play a crucial role in B cell activation and development. X-linked agammaglobulinemia results from mutations in the Btk gene involving the PH domain (202, 203) or SH3 domain (204) of the kinase, among others (205) .
The isolated PH domain of Btk can bind G/3y-subunits in vitro and antagonizes G/3y-dependent signaling when transiently overexpressed in intact cells (42, 43, 185). Interestingly, both Btk and Tsk are activated by the addition of exogenous Gj3y-subunits in an in vitro kinase assay (7). These data suggest that tyrosine kinases may be regulated in a manner analogous to j3ARK and possibly provide a direct link between Gj3y-subunits and tyrosine phosphorylation. Further, Btk appears to interact with, and be regulated by, c-Src (206) (207) (208) (209) , another kinase implicated in GPCR-medi-ated mitogenic signals. Thus far, however, there are no data to suggest that Btk family kinases are involved in regulation of p21ras or MAP kinase pathways. Moreover, limited tissue distribution makes it unlikely that they could provide a general mechanism for Gj87-mediated mitogenic signaling.
Recently, the PTB domain of IRS-1 was shown to share extensive structural similarity with the PLC8 PH domain, despite their affinities for unrelated ligands and their divergent primary amino acid sequences (210, 211) . Like SH2 domains, with which they share no primary or tertiary structural similarity, PTB domains bind with high affinity to context-specific phosphotyrosine residues. Functionally, the PTB, PH, and SH2 domains are each involved in recruiting signaling molecules to the cell surface by binding to different ligands (210) . The structural similarity of PH and PTB domains suggests that ligands common to both domains might exist, although none have been identified.
The mechanism by which G/3y activates the pTyr-dependent signaling cascade to p21ras and ERK remains unclear, although the overall similarities to the classical model of RTK-mediated signaling are striking (Fig. 2) . The emerging roles of c-Src, PI3K, SHP2, and RTKs in this pathway may help to define the sequence of events leading to p21ras activation. These studies are complicated by the fact that many of the proteins which form the mitogenic signaling complex, such as PI3K and SHP2, have dual roles, functioning both as enzymes and as substrates for tyrosine phosphorylation, which creates docking sites for other SH2 domain-containing proteins. Further, concomitant activation of additional effectors, such as adenylyl cyclase and PLC, by Ga-and G/3y-subunits, may have indirect effects on the regulation of the mitogenic signal.
4. Gq/11. The best characterized effector of the PTX-insensitive Gq/11 family of G proteins is PLC. When activated, PLC hydrolyzes phosphatidylinositol, yielding diacylglycerol and inositol phosphates, which in turn regulate intracellular Ca ++ (212) (213) (214) (215) . Ca ++ and diacylglycerol together activate protein kinase C (PKC) enzymes, which regulate a broad array of cellular signals (216) . Treatment of cells with tumorpromoting phorbol esters that directly activate PKC results in the potent activation of ERK. The mechanism by which PKC activates the ERKl/2 kinase cascade is unclear, although it has been suggested that PKC directly phosphorylates and activates Raf in a p21ras-independent manner (217) .
In contrast to Gi-mediated mitogenic signaling, ERK activation by Gq/11-coupled receptors is mostly insensitive to inhibition by the G/3y-sequestrants /3ARKct and a-transducin (66,118,120), indicating that the signal is mediated predominantly by the a-subunit of Gq/11. Since the magnitude of ERK activation by Gq-coupled and Gi-coupled receptors is similar, it is unclear why a larger contribution by Gj3y-subunits to the Gq-mediated signal is not detected. One laboratory has reported that a significant portion of the Gqmediated MlAChR signal in COS-7 cells is GjSy-dependent (117).
The regulation of mitogenic signals by receptors coupled to Gq/11 appears to be mediated by two or more parallel signaling pathways, either p21ras-dependent or -independent. Early observations revealed that mitogenic signals mediated by thrombin and bradykinin were Gq-dependent and involved PLC activation (218) . Furthermore, cellular expression of PLC j32 or a GTPase-deficient mutant of Gaq is sufficient to activate ERK (66).
In COS-7 and CHO cells, the stimulation of ERK activity by Gq-coupled receptors occurs independently of p21ras activation (118) and is insensitive to inhibition by a dominant negative mutant of p21ras (120). However, Gq-mediated signals are inhibited by a dominant negative mutant of Raf (120), indicating that Gaq activates ERK via a p21ras-independent, but Raf-dependent, pathway. The down-regulation of PKC activity in CHO cells by chronic exposure to phorbol ester completely blocks Gq-mediated mitogenic signals, whereas Gi-and RTK-mediated signals are unaffected (120). These observations reveal a Gq-specific mitogenic signaling pathway involving the PLC-mediated activation of PKC and Raf, but not p21ras (Fig. 3) .
Recently, a novel Ca ++ -dependent PTK, PYK2, was cloned . Left, The GTP-bound a-subunit of Gq activates PLC/31, resulting in the conversion of PIP 2 to IP 3 , and diacylglycerol. Diacylglycerol, in turn, contributes to the activation of PKC, which activates Raf kinase via a poorly understood mechanism. Thus, this pathway leads to potent ERKl/2 activation in the apparent absence of p21ras involvement. Right, The GTP-bound a-subunit of Gq activates a series of intracellular signals, including activation of PTKs, PKC, calmodulin, and Ca + + release. Via an as yet undefined mechanism, these signals contribute to the phosphorylation of the She adapter molecule and the subsequent activation of the p21ras/ERK pathway similar to the RTK paradigm (see Fig. 1 ). ERKl/2 activation by Gq-coupled receptors may be further modulated by the contribution of the G protein /37-subunits to the signal (see Fig. 2 ). VAN (221), is a member of the FAK family of non-RTKs, which are known to function in integrin signaling. PYK2, which is highly expressed only in cells of neuronal origin, can be activated either by PKC or elevated levels of intracellular Ca ++ . Stimulation of Gq-coupled bradykinin receptors in PCI2 neuroblastoma cells activates PYK2. The activated kinase in turn mediates p21ras-dependent ERK activation via tyrosine-phosphorylation of She and Shc-Grb2-Sosl complex formation. These observations define a Gq-and Ca + "'"-mediated mitogenic signaling pathway that requires the same intermediates as the Gj3y-and RTK-mediated pathways (Fig. 3) .
In cultured rat vascular smooth muscle cells, PTX-insensitive ERK activation via the endogenous angiotensin II receptor is blocked by intracellular Ca ++ chelation (222) . Interestingly, this Ca ++ -dependent pathway is also completely blocked by the calmodulin inhibitor calmidizolium and the tyrosine kinase inhibitor genistein (223) , suggesting that a Ca ++ /calmodulin-sensitive tyrosine kinase might play a role in the regulation of mitogenic signaling. The cloning of a Ca ++ /calmodulin-stimulated tyrosine kinase has been reported (224) .
Mitogenic signaling via the Gq-coupled prostaglandin F2a and Ml muscarinic receptors in NIH 3T3 cells involves ERK activation via a p21ras-dependent, PKC-independent mechanism (53, 225). In astrocytes, endothelin has been reported to activate Gq-dependent increases in She tyrosine-phosphorylation and Shc-Grb2 complex formation (87). The mechanism by which Gaq stimulates p21ras-dependent ERK activation remains unclear, although this pathway might depend on the activation of a PYK2-like kinase, which functions in a manner analagous to c-Src in Gi-mediated mitogenic signaling (138) (Fig. 3) .
5.
Go. Go is expressed at high levels in neuronal growth cones, where its activity is regulated by GAP-43, a guanine nucleotide-releasing protein known to be involved in the regulation of neuronal growth (226, 227) . Several receptors have been shown to couple to Go in vivo, including Dl dopamine receptors (228), SSTR2 somatostatin receptor (229, 230) , PAF receptor (231), M2 muscarinic receptors (230, 232) , and human 5-HT 1A serotonin receptor (233) . The ability of the PTX-sensitive Go protein to regulate mitogenic signaling was first reported by Kroll et al. (234, 235) , who demonstrated that a constitutively activated, GTPase-deficient mutant of Gao induced transformation of NIH 3T3 fibroblasts and maturation of Xenopus oocytes.
In CHO cells stably transfected with PAF receptor (55, 236, 237) , stimulation leads to a rapid and transient activation of ERK. This signal is sensitive to inhibition by PTX, indicating the involvement of a Gi/o protein, and is abolished by PKC depletion. PAF stimulation does not mediate an increase in p21ras GTP loading (55), and ERK activation is insensitive to inhibition by a dominant negative mutant of p21ras (237) . Sphingosyl phosphorylcholine (61) and LHRH (65) receptors also appear to employ this pathway.
In CHO cells expressing the MlAChR, carbachol stimulation results in PTX-sensitive, PKC-dependent ERK activation (237) . Coexpression of a PTX-insensitive mutant of Gao, but not such a mutated form of Gail, -2, or -3, restores MlAChR-mediated ERK activation in PTX-treated cells. In COS-7 cells, which lack detectable Gao expression, the MlAChR signal is transmitted entirely by PTX-insensitive G proteins, and the PAF receptor does not mediate ERK activation (237) .
B. Other MAP kinases
JNK/SAPK is a member of a novel family of kinases structurally related to ERKs, although it appears to be differentially regulated (238, 244) . Regulation of JNK is associated with the activation of the small molecular weight G proteins, Rac and cdc42 (239, 240) , and proceeds via a kinase cascade involving MEKK and JNKK (241) (242) (243) , whose function is analagous to Raf and MEK in the ERK pathway.
JNK is activated in response to several agonists for GPCRs, including carbachol (240, 241) , PAF (245) , and angiotensin II (246) . Persistent JNK activity is detected in cells expressing GTPase-deficient mutants of Gal2, Gal3 (247), Gal6, and Gaq (248) . In several cases, JNK activation is reported to involve the activation of p21ras (247) and increased intracellular levels of calcium (246, 249) . However, in NIH 3T3 cells, MlAChR-mediated increases in c-jun mRNA and AP-1 activity correlate with the activation of JNK, but not ERK (243) , while stimulation with PDGF activates ERK without stimulating JNK activity. Thus the p21ras/ERK pathway and Rac, cdc42/JNK pathways can be independently regulated.
The low molecular weight G proteins Rac, Rho, and cdc42 are, like p21ras, integrally involved in cellular transformation (250) (251) (252) . Rac, Rho, and cdc42 regulate the formation of stress fibers (actin polymerization), lamellipodia (membrane ruffling), and filopodia, respectively (252) (253) (254) (255) . These cellular and cytoskeletal rearrangements play an important role in growth factor-mediated transformation. Collectively, Rac, Rho, and cdc42 function to activate JNKs (239, 240) , leading to the transcription of nuclear oncogenes.
In Swiss 3T3 cells, Rho proteins mediate the LPA-and bombesin-induced formation of focal adhesions and actin stress fibers (256) . PDGF, insulin, bombesin, and phorbol ester activate Rac, resulting in actin polymerization at the membrane and the formation of membrane ruffles (256) . Actin filament organization in activated mast cells requires the involvement of both heterotrimeric and low molecular weight G proteins (257) .
The mechanism by which heterotrimeric G proteins and GPCRs activate Rac/Rho/cdc42-dependent signaling pathways is unclear. Rho-mediated stress fiber formation in response to LPA or bombesin is unaffected by changes in the levels of cAMP, intracellular calcium, or PKC activity, but significantly attenuated by PTK inhibitors (258) , suggesting that novel signaling mechanisms similar to those regulating the p21ras/ERK pathway exist. The elucidation of the signaling pathways leading from RTKs and GPCRs to the events involved in cytoskeletal rearrangement is crucial to a complete understanding of cellular transformation.
r V. Cross-Talk from RTKs to Heterotrimeric G Proteins
The ERK activation pathway employed by receptors that couple to PTX-sensitive G proteins is mediated by Gfiysubunits and requires the activity of Src family PTKs, which directly or indirectly regulate the tyrosine phosphorylation state of adapter proteins such as She (59,87-91), SHP2 (178), FAK (86) , and possibly the RTKs themselves (126,127). The prospect of such intimate cross-talk between GPCR and RTK signals raises not only the possibility that GPCRs signal via tyrosine phosphorylation cascades, but also that some aspects of RTK signaling might be dependent upon heterotrimeric G proteins (Fig. 2) .
Previous work has suggested that in certain cell types, PTX-sensitive G proteins play a role in some aspects of signaling by the insulin receptor. PTX treatment abolishes insulin-mediated inhibition of lipolysis, attenuates insulinstimulated glucose oxidation in adipocytes (259) , and blocks insulin-mediated inhibition of adenylyl cyclase and insulinstimulated activation of "dense vesicle" cAMP phosphodiesterase (260) in rat hepatocytes. Insulin-stimulated phosphatidylinositol (Pl)-glycan hydrolysis and de novo phosphatidic acid synthesis involves activation of a Gi-requiring Pl-glycan-specific PLC in BC3H-1 myocytes (261, 262) , where PTX treatment also attenuates insulin-stimulated [ 3 H]thymidine incorporation into DNA (262) . Insulin and IGF-1, in contrast to EGF, behave as relatively weak mitogens. Their receptors are closely related proteins that share an a2j32 heterotetrameric structure and, like the EGF receptor, possess ligand-stimulated tyrosine kinase activity (263, 264) . In contrast to the EGF receptor, ligandinduced autophosphorylation of the insulin and IGF-I receptors does not directly create recognition sites, on the receptor molecule, for SH2 domain-containing signaling intermediates. Rather, receptor-catalyzed tyrosine phosphorylation of exogenous adapter proteins, such as IRS-1, IRS-2 (19-21), and She (265) is one of the earliest steps in mitogenesis triggered by these receptors. Phosphorylation of these adapter proteins, therefore, provides the platform for assembly of the mitogenic signaling protein complex, which then proceeds after the EGF receptor paradigm.
In Rat 1 fibroblasts, ERK activation via the endogenous IGF-I receptor and Gi-coupled LPA receptor, but not via the EGF receptor, is sensitive both to PTX treatment and to cellular expression of the j3ARKct peptide (266) . In these cells, IGF-I stimulation results in tyrosine phosphorylation of She, without detectable IRS-1 phosphorylation. The IGF-I, LPA, and EGF receptor-mediated signals are sensitive to inhibitors of PTKs, require p21ras activation, and are independent of PKC. This apparent paradox suggests that in some tissues, the insulin receptor RTKs and Gi protein-coupled receptors employ a similar mechanism for mitogenic signaling that involves both tyrosine phosphorylation and G|3y-subunits derived from PTX-sensitive G proteins.
The mechanism whereby the insulin or IGF-I receptor might promote the generation of free G^7-subunits is unclear, although some data suggest that a direct protein-protein interaction may occur between receptor and G protein.
The a-subunits of Go and Gi, but not Gt, can serve as substrates for insulin receptor-mediated tyrosine phosphorylation in vitro (267) . The stoichiometry of phosphorylation is about 1:1, and the presence of Go or Gi enhances the rate of receptor autophosphorylation, suggesting a stable physical interaction (267) . Insulin also inhibits PTX-catalyzed ADPribosylation of Gi by about 50% in isolated rat liver plasma membranes (268) and promotes guanine-nucleotide binding to BC3H-1 myocyte plasma membranes (269) . In adipocyte plasma membranes (270) , insulin stimulates the binding of GTP to a 40-kDa protein, and binding of GTP leads to a decrease in [ 125 Ilinsulin binding to the receptor, suggesting a feedback interaction between the insulin-stimulated GTPbinding site and the insulin receptor. Further, peptides derived from autophosphorylation sites of the insulin receptor have been shown to directly activate Gi in phospholipid vesicles (271) , and this activation is modulated by tyrosine phosphorylation.
Recently, data obtained in a transgenic mouse model harboring inducible expression of RNA antisense to the gene encoding Gai2 suggest an important physiological interaction between insulin and G protein-signaling pathways (272) . These mice, which exhibit Gai2 deficiency in adipose tissue and liver, display a runted phenotype, hyperinsulinemia, and impaired insulin-induced GLUT4 translocation, inhibition of lipolysis, and activation of glycogen synthase. Insulininduced receptor autophosphorylation is unaffected, but insulin-induced IRS-1 phosphorylation is absent and phosphotyrosine phosphatase activity is increased. While these data do not provide a molecular mechanism for the regulation of G protein-signaling pathways by RTKs, they do indicate a physiologically relevant role for PTX-sensitive G proteins as positive regulators of insulin action.
VI. Conclusions
The involvement of GPCRs and G proteins in the regulation of MAP kinase activity adds a further level of complexity to the study of tumorigenesis, cell division, and differentiation. However, most mitogenic signals appear to be mediated by intermediates that are shared between the G proteins and RTKs, suggesting that local control of growth and differentiation is equally dependent on GPCR and RTK signaling.
The early convergence of mitogenic signaling pathways may facilitate the design of pharmaceuticals for the treatment of diseases involving uncontrolled cell proliferation. Thus, a complete understanding of mitogenic signaling mechanisms is vitally important to the study of the pathophysiology of diseases such as, for example, postangioplasty restenosis, tumorigenesis, atherosclerosis, and proliferative complications of diabetes. 
